[Therapy of herpes zoster and postherpetic neuralgia].
Therapie des Herpes zoster und der postherpetischen Neuralgie.
Aciclovir
Analgesics
Neuropathic pain
Vaccination
WHO analgesic ladder
Journal
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
ISSN: 1432-1173
Titre abrégé: Hautarzt
Pays: Germany
ID NLM: 0372755
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
pubmed:
5
7
2019
medline:
26
9
2019
entrez:
5
7
2019
Statut:
ppublish
Résumé
Herpes zoster (HZ) is caused by the reactivation of varicella zoster virus. The incidence of herpes zoster and associated problems increases with age. With a life-long prevalence of 30%, every second 85-year-old person experiences HZ once in his lifetime. Three therapeutic columns are based on antiviral, topical and analgetic therapies. An extreme handicap is acute and persistent pain which can develop into postherpetic neuralgia (PHN). Those pain symptoms are predominantly neuropathic. The management of acute and chronic manifestation of pain may be challenging. HZ vaccination represents a substantial improvement in terms of prevention of herpes zoster and reduction of long-term complications, such as PHN. The permanent vaccination commission of the Robert Koch Institute recommends vaccination with dead virus for all persons over the age of 60 years. Risk groups like immunosuppressed patients are advised to be vaccinated starting at the age of 50 years.
Identifiants
pubmed: 31270550
doi: 10.1007/s00105-019-4446-0
pii: 10.1007/s00105-019-4446-0
doi:
Substances chimiques
Antiviral Agents
0
Herpes Zoster Vaccine
0
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
645-656Commentaires et corrections
Type : ErratumIn
Références
Hautarzt. 2001 Apr;52(4):359-76
pubmed: 11382132
J R Coll Gen Pract. 1975 Aug;25(157):571-5
pubmed: 1195231
Schmerz. 1997 Dec 12;11(6):373-7
pubmed: 12799794
N Engl J Med. 2005 Jun 2;352(22):2271-84
pubmed: 15930418
Curr Med Res Opin. 2006 Oct;22(10):1911-20
pubmed: 17022849
Zhongguo Zhen Jiu. 2007 Jul;27(7):536-40
pubmed: 17722838
Nurs Stand. 2008 Jun 4-10;22(39):49-56; quiz 58, 60
pubmed: 18578133
Clin Drug Investig. 2009;29(6):393-408
pubmed: 19432499
Curr Med Res Opin. 2009 Jul;25(7):1663-76
pubmed: 19485723
Pain Med. 2010 Apr;11(4):600-8
pubmed: 20113411
Altern Ther Health Med. 2010 Nov-Dec;16(6):48-54
pubmed: 21280462
N Engl J Med. 2013 Jul 18;369(3):255-63
pubmed: 23863052
Hautarzt. 2014 May;65(5):461-70; quiz 471-2
pubmed: 24820804
N Engl J Med. 2015 May 28;372(22):2087-96
pubmed: 25916341
J Dtsch Dermatol Ges. 2015 Oct;13(10):967-89
pubmed: 26408456
Hautarzt. 2016 Aug;67(8):653-65
pubmed: 27389412
Pain Med. 2017 Aug 1;18(8):1566-1572
pubmed: 27492741
N Engl J Med. 2016 Sep 15;375(11):1019-32
pubmed: 27626517
Pain Ther. 2016 Dec;5(2):127-133
pubmed: 27743137
J Eur Acad Dermatol Venereol. 2017 Jan;31(1):9-19
pubmed: 27804172
Pain Med. 2017 Oct 1;18(10):1837-1863
pubmed: 28034973
Hautarzt. 2018 Jan;69(1):48-57
pubmed: 28983646
Medicine (Baltimore). 2018 Aug;97(34):e11986
pubmed: 30142834
BMC Infect Dis. 2018 Oct 3;18(1):496
pubmed: 30285731
Mayo Clin Proc. 2019 May;94(5):763-775
pubmed: 30955916